
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exosome-transmitted circ_002136 promotes hepatocellular carcinoma progression by miR-19a-3p/RAB1A pathway
Peng Yuan, Jinhua Song, Fei Wang, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Peng Yuan, Jinhua Song, Fei Wang, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Showing 20 citing articles:
Cancer-derived exosomes as novel biomarkers in metastatic gastrointestinal cancer
Danyang Zhong, Ziyuan Wang, Zhichao Ye, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Danyang Zhong, Ziyuan Wang, Zhichao Ye, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16
Exosome-Delivered Hsa_Circ_0000116 Facilitates Osteosarcoma Cell Malignancy via PI3K/Akt/mTOR and p38/MAPK Pathways
Chunsheng Gao, Xiaowei Wang, Hui‐chao Yan, et al.
DNA and Cell Biology (2025)
Closed Access | Times Cited: 1
Chunsheng Gao, Xiaowei Wang, Hui‐chao Yan, et al.
DNA and Cell Biology (2025)
Closed Access | Times Cited: 1
Circ_0098823 binding with IGF2BP3 regulates DNM1L stability to promote metastasis of hepatocellular carcinoma via mitochondrial fission
Jiuliang Yan, Xiaofeng Wang, Zongyu Fan, et al.
APOPTOSIS (2024) Vol. 29, Iss. 5-6, pp. 709-725
Closed Access | Times Cited: 7
Jiuliang Yan, Xiaofeng Wang, Zongyu Fan, et al.
APOPTOSIS (2024) Vol. 29, Iss. 5-6, pp. 709-725
Closed Access | Times Cited: 7
Lactadherin immunoblockade in small extracellular vesicles inhibits sEV-mediated increase of pro-metastatic capacities
Eduardo Durán-Jara, Matías del Campo, Valentina Gutiérrez, et al.
Biological Research (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 5
Eduardo Durán-Jara, Matías del Campo, Valentina Gutiérrez, et al.
Biological Research (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 5
Advances and challenges of exosome-derived noncoding RNAs for hepatocellular carcinoma diagnosis and treatment
Min Shi, Jun-Su Jia, Guosheng Gao, et al.
Biochemistry and Biophysics Reports (2024) Vol. 38, pp. 101695-101695
Open Access | Times Cited: 5
Min Shi, Jun-Su Jia, Guosheng Gao, et al.
Biochemistry and Biophysics Reports (2024) Vol. 38, pp. 101695-101695
Open Access | Times Cited: 5
Exosomal ncRNAs: Multifunctional contributors to the immunosuppressive tumor microenvironment of hepatocellular carcinoma
Qi Huang, Xin Zhong, Jing Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116409-116409
Open Access | Times Cited: 4
Qi Huang, Xin Zhong, Jing Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116409-116409
Open Access | Times Cited: 4
Inhibiting angiogenesis and osteogenesis by targeted regulation of KLK4 via the exosomal MiR-422a derived from bone mesenchymal stem cells
Qifei He, Qianzheng Zhuang, Z. Y. Deng, et al.
Biotechnology and Bioprocess Engineering (2025)
Closed Access
Qifei He, Qianzheng Zhuang, Z. Y. Deng, et al.
Biotechnology and Bioprocess Engineering (2025)
Closed Access
Migrasome Marker Epidermal Growth Factor Domain-Specific O-GlcNAc Transferase: Pan-Cancer Angiogenesis Biomarker and the Potential Role of circ_0058189/miR-130a-3p/EOGT Axis in Hepatocellular Carcinoma Progression and Sorafenib Resistance
Zhe Yu, Jing Luo, Wen An, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 773-773
Open Access
Zhe Yu, Jing Luo, Wen An, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 773-773
Open Access
Extracellular vesicles and cancer stemness in hepatocellular carcinoma – is there a link?
Lü Tian, Jingyi Lu, Irene Oi‐Lin Ng
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Lü Tian, Jingyi Lu, Irene Oi‐Lin Ng
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Extracellular Vesicle-Related Non-Coding RNAs in Hepatocellular Carcinoma: An Overview
Giuseppa Augello, Alessandra Cusimano, Melchiorre Cervello, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1415-1415
Open Access | Times Cited: 3
Giuseppa Augello, Alessandra Cusimano, Melchiorre Cervello, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1415-1415
Open Access | Times Cited: 3
Spotlights on extracellular vesicles in hepatocellular carcinoma diagnosis and treatment: an update review
Caizheng Wang, Xiaoying Zhang, Jiahui Yu, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 7
Caizheng Wang, Xiaoying Zhang, Jiahui Yu, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 7
Interplay among extracellular vesicles, cancer stemness and immune regulation in driving hepatocellular carcinoma progression
Yu‐Man Tsui, Lü Tian, Jingyi Lu, et al.
Cancer Letters (2024) Vol. 597, pp. 217084-217084
Open Access | Times Cited: 2
Yu‐Man Tsui, Lü Tian, Jingyi Lu, et al.
Cancer Letters (2024) Vol. 597, pp. 217084-217084
Open Access | Times Cited: 2
Circular RNAs in human diseases
Yuanyong Wang, Jin Zhang, Yu‐Chen S. H. Yang, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 2
Yuanyong Wang, Jin Zhang, Yu‐Chen S. H. Yang, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 2
Non-coding RNAs in hepatocellular carcinoma metastasis: Remarkable indicators and potential oncogenic mechanism
Wenqi Qiu, Song Zhang, Wei Yu, et al.
Computers in Biology and Medicine (2024) Vol. 180, pp. 108867-108867
Closed Access | Times Cited: 1
Wenqi Qiu, Song Zhang, Wei Yu, et al.
Computers in Biology and Medicine (2024) Vol. 180, pp. 108867-108867
Closed Access | Times Cited: 1
Role of exosomal ncRNAs released by M2 macrophages in tumor progression of gastrointestinal cancers
Abdo Meyiah, Murad Alahdal, Eyad Elkord
iScience (2023) Vol. 26, Iss. 4, pp. 106333-106333
Open Access | Times Cited: 4
Abdo Meyiah, Murad Alahdal, Eyad Elkord
iScience (2023) Vol. 26, Iss. 4, pp. 106333-106333
Open Access | Times Cited: 4
Exosomes and circular RNAs: promising partners in hepatocellular carcinoma from bench to bedside
Meng‐Yuan Hu, Xue Li, Zhenluo Jiang, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Meng‐Yuan Hu, Xue Li, Zhenluo Jiang, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Decoding the interaction between miR-19a and CBX7 focusing on the implications for tumor suppression in cancer therapy
Arefeh Zabeti Touchaei, Sogand Vahidi, Ali Akbar Samadani
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 3
Arefeh Zabeti Touchaei, Sogand Vahidi, Ali Akbar Samadani
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 3
Exosomal circRNAs: Deciphering the novel drug resistance roles in cancer therapy
Xi Li, Hanzhe Liu, Peiyu Xing, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 15, Iss. 2, pp. 101067-101067
Open Access
Xi Li, Hanzhe Liu, Peiyu Xing, et al.
Journal of Pharmaceutical Analysis (2024) Vol. 15, Iss. 2, pp. 101067-101067
Open Access
Extracellular Vesicles in the HCC Microenvironment: Implications for Therapy and Biomarkers
Le Cheng, Limin Zhang, Xiaoxiao Wang, et al.
Pharmacological Research (2024), pp. 107419-107419
Open Access
Le Cheng, Limin Zhang, Xiaoxiao Wang, et al.
Pharmacological Research (2024), pp. 107419-107419
Open Access
Insights about exosomal circular RNAs as novel biomarkers and therapeutic targets for hepatocellular carcinoma
Haiyan Zhang, Shanshan Pei, Jiaxuan Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Haiyan Zhang, Shanshan Pei, Jiaxuan Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access